Pretreatment Tumor Growth Rate Is a Temporal Biomarker That Predicts Treatment Failure and Improves Risk Stratification for Oropharyngeal Cancer

Journal article

C.T. Murphy, K. Devarajan, L. Wang, R. Mehra, J.A. Ridge, C. Fundakowski and T.J. Galloway

International journal of radiation oncology, biology, physics, Vol.93(3), pp.S173-S174

2015-11

Metrics

1 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Pretreatment Tumor Growth Rate Is a Temporal Biomarker That Predicts Treatment Failure and Improves Risk Stratification for Oropharyngeal Cancer
Creators: C.T. Murphy - Fox Chase Cancer Center
K. Devarajan - Fox Chase Cancer Center
L. Wang - Fox Chase Cancer Center
R. Mehra - Fox Chase Cancer Center
J.A. Ridge - Fox Chase Cancer Center
C. Fundakowski - Fox Chase Cancer Center
T.J. Galloway - Fox Chase Cancer Center
Publication Details: International journal of radiation oncology, biology, physics, Vol.93(3), pp.S173-S174
Academic Unit: Miller School of Medicine; UMMG Dept of Radiation Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031725744702976